GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
GeneDx reported a 34% year-over-year growth in volume for exome and genome testing in their first quarter financial results for 2026.
GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx reported first quarter financial results and business highlights, including 34% year-over-year volume growth in exome and genome testing.